Results 31 to 40 of about 2,988 (157)

Estudos sobre o xanthoma: biochimica e pathogenia Studies in xanthoma: biochemistry and pathogenesis

open access: yesMemorias do Instituto Oswaldo Cruz, 1935
1. No presente trabalho são descriptos dois casos de xanthelasmatose (xanthoma) com perturbações accentuadas do metabolismo dos lipides e esteroes. 2. Um dos casos apresentou notavel cholesteroluria não mostrando o doente lesões renaes, ao passo que o ...
Gilberto G. Villela, Rabello Junior
doaj   +1 more source

Cherry Anthocyanins Regulate NAFLD by Promoting Autophagy Pathway

open access: yesOxidative Medicine and Cellular Longevity, Volume 2019, Issue 1, 2019., 2019
Nonalcoholic fatty liver disease (NAFLD) is a common chronic disease that threatens human health, and present therapies remain limited due to the lack of effective drugs. Lipid metabolic disturbance and oxidative stress have strong links to the development of NAFLD, while autophagy was generally accepted as a key regulatory mechanism on these steps ...
Qiang Chu   +7 more
wiley   +1 more source

Lipid Storage Myopathy in Behçet′s Disease: A Rare Cause of Elevated Serum Creatine Kinases Levels

open access: yesCase Reports in Rheumatology, Volume 2012, Issue 1, 2012., 2012
Muscular involvement in Behçet’s disease is rare and there are only a few case reports in the literature. The causes of elevated muscle enzymes in a patient with Behcet’s disease are many, including myositis, drug‐induced myopathy, metabolic myopathy, and the disease itself.
Sedat Yilmaz   +9 more
wiley   +1 more source

Phospholipogenic Pharmaceuticals Are Associated with a Higher Incidence of Histological Findings than Nonphospholipogenic Pharmaceuticals in Preclinical Toxicology Studies

open access: yesJournal of Toxicology, Volume 2012, Issue 1, 2012., 2012
While phospholipidosis is thought to be an adaptive response to chemical challenge, many phospholipogenic compounds are known to display adverse effects in preclinical species and humans. To investigate the link between phospholipogenic administration and incidence of preclinical histological signals, an internal AstraZeneca in vivo toxicology report ...
Linda R. Barone   +5 more
wiley   +1 more source

Gaucher Disease and the Synucleinopathies

open access: yesBioMed Research International, Volume 2006, Issue 1, 2006., 2006
Several recent observations suggest a connection between Gaucher disease, the inherited deficiency of glucocerebrosidase, and the synucleinopathies. Rare patients have been observed who develop both Gaucher disease and parkinsonism. Autopsy studies on these subjects reveal synuclein‐positive Lewy bodies and inclusions.
Kathleen S. Hruska   +2 more
wiley   +1 more source

From pollen provision to pollinator: Species‐specific sterol assimilation by wild bees in urban landscapes

open access: yesFunctional Ecology, Volume 40, Issue 6, Page 1906-1920, June 2026.
Read the free Plain Language Summary for this article on the Journal blog. Abstract Human‐driven landscape change, particularly urbanization, is reshaping pollinator communities, yet the functional traits that mediate species persistence remain poorly understood. Dietary specialization is commonly used to predict species vulnerability.
Yan Yang   +5 more
wiley   +1 more source

Mortality Trends and Causes of Death in Myotonic Dystrophy Type 1 Patients From the UK Clinical Practice Research Datalink

open access: yesMuscle &Nerve, Volume 71, Issue 2, Page 229-236, February 2025.
ABSTRACT Introduction/Aim Patients with myotonic dystrophy type1 (DM1) have reduced lifespan. This study aimed to quantify mortality risks, and evaluate causes and time trends in DM1. Methods We identified 1021 DM1 patients and 15,104 matched DM1‐free controls from the United Kingdom (UK) Clinical Practice Research Datalink.
Rotana Alsaggaf   +5 more
wiley   +1 more source

Old disease—New reflections: Gaucher, immunity, and inflammation

open access: yesJournal of Cellular and Molecular Medicine, Volume 28, Issue 20, October 2024.
Abstract Gaucher disease (GD) is the most common lysosomal storage disease. It is a multisystemic metabolic disease caused by GBA pathogenic mutations. Although the general symptoms have been known for a long time, new treatment possibilities, the detection of different biomarkers, and innovations in diagnosis and follow‐up have paved the way for ...
Can Veysel Şoroğlu, Ezgi Gizem Berkay
wiley   +1 more source

History of study on metabolic myopathy

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2014
The developmental history of metabolic myopathy is reviewed both chronologically and from different classifications. Searching the specific biomarkers of different metabolic myopathies, and specific diagnostic and therapeutic measures targeting these ...
Jian YIN   +4 more
doaj  

Home - About - Disclaimer - Privacy